The White Hat Life Science Investor Conference, a biotech and healthcare investor conference, will showcase exciting biotech and medtech companies from across the Rocky Mountain & Southwest Region September 28-29, 2022 during Arizona Bioscience Week.
Investors will have the opportunity to connect with a new generation of biotech and healthcare pioneers in person and to schedule meetings via the Arizona Bioscience Week app.Continue reading
Rep. Greg Stanton announced today that a $1 million federal investment that he secured for Maricopa Community Colleges to support the development of its bioscience program has been included in an appropriations bill the House will soon consider.
The funds will help Maricopa Community Colleges develop and expand its STEM curriculum, create additional seats to prepare students for good-paying careers as lab technicians, bioscience quality systems managers, and bioscience process managers. The program will build the pipeline for STEM-focused jobs, where job growth continues to outpace the number of qualified individuals available to fill those jobs.Continue reading
On Sunday, August 7, 2022, the United States Senate passed the Inflation Reduction Act of 2022 in a party line vote with Vice President Kamala Harris casting the tie breaking vote. The legislation now moves back to the House of Representatives. Speaker Pelosi stated, “The House will return and move swiftly to send this bill to the President’s desk ….”
Dylan’s work will focus on supporting the AZBioPEERS education and AZBioPEERS Mentoring programs, supporting the AZAdvances Initiative, and developing our talent pipeline.Continue reading
Researchers, PIs, Technologists: Learn about opportunities to develop your wearable solutions a part of WearTech Center’s next applied research cohort with matching funding up to$250,000.Continue reading
Dr. Janko Nikolich-Žugich’s past experiences left him uniquely prepared to fight a global pandemic – and help prevent the next one.Continue reading
Interns showcase their work at day-long scientific symposiumContinue reading
Researchers explore possible effects in the brainContinue reading
New analysis shows that under such policies only 6 of 110 currently approved therapies would have made it to the market because companies would no longer have the necessary funds to invest in research and development and innovative partnerships with small biotech.
Further, the proposed legislation will also likely lead to the loss of over 590,000 US biopharma jobs.Continue reading
The University of Arizona has licensed the new class of drugs designed to penetrate the blood-brain barrier to startup Teleport Pharmaceuticals.Continue reading